Biodesix, Inc.
BDSX
$0.8622
$0.01221.44%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.15M | 17.93M | 14.82M | 14.67M | 13.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.15M | 17.93M | 14.82M | 14.67M | 13.49M |
| Cost of Revenue | 4.18M | 3.88M | 3.18M | 3.37M | 3.23M |
| Gross Profit | 13.97M | 14.05M | 11.64M | 11.29M | 10.26M |
| SG&A Expenses | 20.02M | 19.66M | 20.56M | 16.25M | 15.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.74M | 26.10M | 25.77M | 21.51M | 20.66M |
| Operating Income | -8.59M | -8.17M | -10.95M | -6.85M | -7.17M |
| Income Before Tax | -10.26M | -10.81M | -13.61M | -9.14M | -10.95M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.26M | -10.81M | -13.61M | -9.14M | -10.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.26M | -10.81M | -13.61M | -9.14M | -10.95M |
| EBIT | -8.59M | -8.17M | -10.95M | -6.85M | -7.17M |
| EBITDA | -7.10M | -6.76M | -9.53M | -5.87M | -6.39M |
| EPS Basic | -0.07 | -0.09 | -0.14 | -0.10 | -0.14 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.09 | -0.06 | -0.09 |
| EPS Diluted | -0.07 | -0.09 | -0.14 | -0.10 | -0.14 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.09 | -0.06 | -0.09 |
| Average Basic Shares Outstanding | 146.30M | 127.17M | 97.17M | 92.33M | 79.71M |
| Average Diluted Shares Outstanding | 146.30M | 127.17M | 97.17M | 92.33M | 79.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
